Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
11.49
+0.04 (0.35%)
Apr 30, 2026, 3:04 PM CST

SHE:301211 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
33.834.9191.55176.12125.79121.65
Depreciation & Amortization
43.3743.3725.4321.6621.7619.37
Other Amortization
0.290.290.290.1--
Loss (Gain) From Sale of Assets
-0.01-0.01--0.18-0.040.07
Asset Writedown & Restructuring Costs
0.020.020.112.580.660
Loss (Gain) From Sale of Investments
-29.14-29.14-19.03-4.02--10.7
Provision & Write-off of Bad Debts
0.230.230.07-0.6-1.721.02
Other Operating Activities
-1.745.67-1.76-3.5-4.594.42
Change in Accounts Receivable
-14.14-14.141.2749.3131.65-61.53
Change in Inventory
10.8310.8335.95-59.1-25.2145.09
Change in Accounts Payable
-45.26-45.26-39.44-46.29100.93.92
Operating Cash Flow
-0.977.5596.07137.06250.79123.98
Operating Cash Flow Growth
--92.14%-29.91%-45.35%102.28%1.90%
Capital Expenditures
-44.75-52.33-164.43-186.53-75.95-21.07
Sale of Property, Plant & Equipment
0.030.030.090.470.060.01
Investment in Securities
29.25-0.75-949.58-21.4-103.98240
Other Investing Activities
13.6215.764.45--10.7
Investing Cash Flow
-1.86-37.29-1,109-207.47-179.86229.65
Long-Term Debt Repaid
--1.4-1.63--1.33-
Net Debt Issued (Repaid)
-1.4-1.4-1.63--1.33-
Issuance of Common Stock
-----1,416
Common Dividends Paid
-72-72-138.24-96-72-
Other Financing Activities
----1.17-4.06-11.02
Financing Cash Flow
-73.4-73.4-139.87-97.17-77.391,405
Foreign Exchange Rate Adjustments
-2.02-1.142.073.814.93-4.42
Net Cash Flow
-78.25-104.28-1,151-163.76-1.531,754
Free Cash Flow
-45.72-44.78-68.36-49.47174.84102.92
Free Cash Flow Growth
----69.89%-4.96%
Free Cash Flow Margin
-9.96%-9.88%-15.33%-7.46%33.96%19.04%
Free Cash Flow Per Share
-0.11-0.10-0.16-0.120.420.33
Cash Income Tax Paid
6.798.678.7932.928.7332.4
Levered Free Cash Flow
-48.35-57.02-94.01-118.8102.264.84
Unlevered Free Cash Flow
-48.24-56.91-93.82-118.61102.4264.84
Change in Working Capital
-47.79-47.79-0.59-55.1108.93-11.85
Source: S&P Global Market Intelligence. Standard template. Financial Sources.